Carnegie Capital Asset Management »

SPDR S&P Biotech shares owned by Carnegie Capital Asset Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Carnegie Capital Asset Management from 13F filings

Historical chart of Carnegie Capital Asset Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Carnegie Capital Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Carnegie Capital Asset Management

Quarter filed Position value Share count Share price at filing
2012-12-31 $1.9M 22k 87.92

More positions owned by Carnegie Capital Asset Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Sherwin-Williams Company (SHW)
Mastercard Incorporated Cl A (MA)
NVIDIA Corporation (NVDA)
Eaton Corp SHS (ETN)
Progressive Corporation (PGR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Adobe Systems Incorporated (ADBE)
Alphabet Cap Stk Cl C (GOOG)
Zoetis Cl A (ZTS)

View all positions for Carnegie Capital Asset Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Citadel Advisors
Millennium Management
UBS Group
Bank of America Corporation
Citigroup
venBio Select Advisor
Jpmorgan Chase & Co
Nantahala Capital Management
Healthcare Of Ontario Pension Plan Trust Fund
Moore Capital Management
Barclays
Perceptive Advisors
Gts Securities
Brown Advisory Holdings Incorporated

View all funds holding SPDR S&P Biotech